The clinical performance of digital breast tomosynthesis-guided vacuum-assisted breast biopsy: a single-institution experience in Japan

2019 ◽  
Vol 45 (2) ◽  
pp. e102
Author(s):  
M. Ido ◽  
T. Ando ◽  
Y. Ito ◽  
J. Kousaka ◽  
Y. Mouri ◽  
...  

Author(s):  
Kyoko Goda ◽  
Maki Tanaka ◽  
Miki Yamaguchi ◽  
Hiroko Otsuka ◽  
Shigeru Sakata ◽  
...  






2011 ◽  
Author(s):  
Laurence Vancamberg ◽  
Nausikaa Geeraert ◽  
Razvan Iordache ◽  
Giovanni Palma ◽  
Rémy Klausz ◽  
...  


2017 ◽  
Vol 72 (1) ◽  
pp. 95.e9-95.e15 ◽  
Author(s):  
P. Whelehan ◽  
S.H. Heywang-Köbrunner ◽  
S.J. Vinnicombe ◽  
A. Hacker ◽  
A. Jänsch ◽  
...  


Radiology ◽  
2019 ◽  
Vol 290 (2) ◽  
pp. 298-304 ◽  
Author(s):  
Manisha Bahl ◽  
Mary Maunglay ◽  
Helen Anne D’Alessandro ◽  
Constance D. Lehman


Radiology ◽  
2015 ◽  
Vol 274 (3) ◽  
pp. 654-662 ◽  
Author(s):  
Simone Schrading ◽  
Martina Distelmaier ◽  
Timm Dirrichs ◽  
Sabine Detering ◽  
Liv Brolund ◽  
...  


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Olena Weaver ◽  
Ethan O. Cohen ◽  
Rachel E. Perry ◽  
Hilda H. Tso ◽  
Kanchan Phalak ◽  
...  

Abstract Background Mammography-guided vacuum-assisted biopsies (MGVAB) can be done with stereotaxis or digital breast tomosynthesis guidance. Both methods can be performed with a conventional (CBA) or a lateral arm biopsy approach (LABA). Marker clip migration is relatively frequent in MGVAB (up to 44%), which in cases requiring surgery carries a risk of positive margins and re-excision. We aimed to compare the rates of clip migration and hematoma formation between the CBA and LABA techniques of prone MGVAB. Our HIPAA compliant retrospective study included all consecutive prone MGVAB performed in a single institution over a 20-month period. The LABA approach was used with DBT guidance; CBA utilized DBT or stereotactic guidance. The tissue sampling techniques were otherwise identical. Results After exclusion, 389 biopsies on 356 patients were analyzed. LABA was done in 97 (25%), and CBA in 292 (75%) cases. There was no statistical difference in clip migration rate with either 1 cm or 2 cm distance cut-off [15% for CBA and 10% for LABA for 1 cm threshold (p = 0.31); 5.8% or CBA and 3.1% or LABA for 2 cm threshold (p = 0.43)]. There was no difference in the rate of hematoma formation (57.5% in CDB and 50.5% in LABA, p = 0.24). The rates of technical failure were similar for both techniques (1.7% for CBA and 3% for LABA) with a combined failure rate of 1%. Conclusions LABA and CBA had no statistical difference in clip migration or hematoma formation rates. Both techniques had similar success rates and may be helpful in different clinical situations.





2017 ◽  
Vol 14 (04) ◽  
pp. 214-220
Author(s):  
Rüdiger Schulz-Wendtland ◽  
P. Dankerl ◽  
M. Bani ◽  
P. Fasching ◽  
K. Heusinger ◽  
...  

Abstract Introduction The placement of intramammary marker clips has proven to be helpful for tumor localization in patients undergoing neoadjuvant chemotherapy and breast-conserving surgery. The purpose of our study was to investigate the feasibility of using a clip marker system for breast cancer localization and its influence on the imaging assessment of treatment responses after neoadjuvant chemotherapy. Patients and Methods Between March and June 2015, a total of 25 patients (n = 25), with a suspicion of invasive breast cancer with diameters of at least 2 cm (cT2), underwent preoperative sonographically guided core needle biopsy using a single-use breast biopsy system (HistoCore™) and intramammary clip marking using a directly adapted clip system based on the established O-Twist Marker™, before their scheduled preoperative neoadjuvant chemotherapy. Localization of the intramammary marker clip was controlled by sonography and digital breast tomosynthesis. Results Sonography detected no dislocation of intrammammary marker clips in 20 of 25 patients (80 %), while digital breast tomosynthesis showed accurate placement without dislocation in 24 patients (96 %) (p < 0.05). There was no evidence of significant clip migration during preoperative follow-up imaging after neoadjuvant chemotherapy. No complication related to the clip marking was noted and there was no difficulty in evaluating the treatment response to neoadjuvant chemotherapy. Among the breast-conserving surgeries performed, no cases were identified in which intraoperative loss of the marker clip had occurred. Conclusion Our study underscores the importance of intramammary marking clip systems before neoadjuvant chemotherapy. Placement of marker clips is advised to facilitate accurate tumor bed localization. With regard to digital breast tomosynthesis, its development continues to improve the quality of diagnostics and the therapy of breast cancer particularly for small breast cancer tumors or in neoadjuvant chemotherapy setting.



Sign in / Sign up

Export Citation Format

Share Document